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Abstract: Basal cell carcinoma (BCC) seems to originate from
ultraviolet light-induced mutations involving the bulge or the outer
sheath of the hair follicle cells. However, the etiopathogenic
mechanisms involved in the development of these tumors in
nonphotoexposed and in hairless areas remain unclear. The cytoker-
atin (CK) proﬁle (including CK5/6, CK7, CK14, CK15, CK17, and
CK19) from a series of different BCC subtypes developing in
sun-exposed and non–sun-exposed areas, including hairless regions,
was evaluated. The authors have observed that CK7 expression in
BCC is associated with the anatomical localization of the tumor and
its sun-exposition, but not with other factors such as histological
subtype. The expression of this CK is higher in BCCs located in
non–sun-exposed and nonhairy areas, such as the vulvar semimucosa
and the nipple. Because CK7 is a marker of simple glandular
epithelia, the authors suggest a glandular origin for BCCs located
in hairless and nonphotoexposed areas.
Key Words: basal cell carcinoma, cytokeratins, hair follicle, sebaceous
gland, photoexposition
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INTRODUCTION
Basal cell carcinoma (BCC) is the most common
malignancy in whites. BCC often arises on sun-exposed
areas such as the face and upper trunk and shows slow growth
and a variable locally aggressive behavior.1 The cellular ori-
gin of the BCC is not completely elucidated, but development
of BCC from both the stem cell of the outer sheath of the hair
follicle or hair bulge has been hypothesized.2 Some authors
have suggested that a subset of BCC may arise from the
interfollicular epithelium.3,4 In patients with Gorlin syndrome
(nevoid BCC syndrome), germ-line mutations in the PTCH1
gene have been demonstrated and molecular somatic muta-
tions in the PTCH1 gene and other genes encoding proteins of
the hedgehog pathway have also been detected in sporadic
BCC.5–8 However, somatic mutations in BCC usually show
the characteristic pattern of UV-induced mutations.9
Cytokeratins (CK) constitute intermediate ﬁlaments of
epithelial cells, forming part of the cellular cytoskeleton.10
Malignant tumor cells tend to retain the CK expression pattern
of the original cells and can be used as potential markers to
determine either the origin of a tumor and to conﬁrm the nature
of metastatic cancer of unknown origin.11 Several studies have
been performed to evaluate CK expression in BCC.12–16 How-
ever, in large series of tumors, no clear-cut differences
regarding the expression pattern in different clinical and histo-
pathological variants of BCC have been detected. However, as
far as we are concerned, no previous studies have evaluated the
CK expression proﬁle in BCC in relation to both the exposure
to sunlight and anatomic location.
MATERIALS AND METHODS
Biopsies
Sixty-seven skin biopsy samples were retrospectively
obtained from the Dermatology Pathology ﬁles at the Arnau de
Vilanova University Hospital (Hospital Universitari Arnau de
Vilanova), and Biomedical Research Institute’s Biobank
(IRBLleida Biobank) in Lleida, Spain. Both institutions were
authorized by the Department of Health of the Government of
Catalonia as from April 29, 2013, and registered on the
National Register of Biobanks of the Carlos III Health Institute
(Spain) under reference number B.0000682. The Biobank
guarantees the traceability and quality of the samples and the
consent process undertaken in accordance with the protocols
approved by the Local Ethical Committee following the basic
principles (respect for the individual), operational risk-
management (risk–beneﬁt), and guidelines (good clinical
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practice) of the Declaration of Helsinki (World Medical
Association, 1964). The included samples had been selected
according to the area involved, including only samples of BCC
developing in chronic or intermittent sun-exposed areas and in
non–sun-exposed areas.
The following data were recorded for each patient with
BCC: sex, age, solar elastosis, tumor differentiation, and
tumoral localization (see Tables 1–3, Supplemental Digital
Content 1, http://links.lww.com/AJDP/A59). Thirty BCCs
had developed in a chronic photoexposed area (face) (group
1); 22 BCCs arising in an intermittent photoexposed area
(upper trunk) (group 2), including a case of BCC on a man’s
nipple, and 15 BCCs developing in nonphotoexposed locations
(group 3), including 5 vulvar BCCs (hairy area), 4 BCCs
located on the inner part of the labia majora (semimucous
membrane) (a hairless area), 1 on the perineum, 1 on the
female mons pubis, 1 on the female breast, and 3 on axillae.
Histopathological Evaluation
Following a systematized protocol, a panel of histo-
pathological features was blindly evaluated by 2 independent
observers. BCCs were classiﬁed as superﬁcial, nodular, or
inﬁltrating BCC. Tissue blocks were sectioned at a thickness
of 3 mm, dried for 1 hour at 658 before pretreatment procedure
of deparafﬁnization, rehydration, and epitope retrieval in the
Pre-Treatment Module, PT-LINK (DAKO) at 958C for 20
minutes in ·50 Tris/EDTA buffer, pH 9. Before staining the
sections, endogenous peroxidase activity was blocked.
Anti-CK monoclonal antibodies against CK5/6 (DAKO,
Glostrup, Denmark), CK7 (DAKO, Glostrup, Denmark),
CK14 (Leica, Newcastle, United Kingdom), CK15 (Leica,
Newcastle, United Kingdom), CK17 (DAKO, Glostrup,
Denmark), and CK19 (DAKO, Glostrup, Denmark) were eval-
uated (Table 1).17 After incubation, the reaction was visualized
with the EnVision FLEX Detection Kit (DAKO, Glostrup,
Denmark) using diaminobenzidine chromogen as a substrate.
Sections were counterstained with hematoxylin.
Immunohistochemical results were evaluated by
following uniform preestablished criteria. Immunoexpression
was graded semiquantitatively (histoscore) by considering the
percentage of cells stained (0%, 25%, 50%, 75%, and 100%) and
intensity of the staining (negative staining, 0; light, 1; moderate,
2; and intense, 3). The maximum value was 300. Results of this
histoscore were subjected to statistical analysis. Mean and
SD were computed to deﬁne immunoexpression levels. The
Mann–Whitney or Kruskal–Wallis test was conveniently used to
assess the differences between sample types. A linear model was
also used to adjust for potentially confounding variables (sex and
age). A multivariate logistic regression model was ﬁtted to
determine a molecular-based proﬁle associated with photoexpo-
sition. Sensitivity and speciﬁcity analysis was performed to
assess its reproducibility, computing the area under the Receiver
Operating Characteristic (ROC) curve. All analyses were per-
formed using R statistical package, and the threshold for signif-
icance was set at 5% (a = 0.05).
Other histopathological data were also analyzed as
a second objective such as tumor differentiation (follicular,
apocrine/eccrine or sebaceous) and BCC subtype to correlate
with the CK expression. The criteria used in this work to
diagnose adnexal differentiation in BCC were as follows18
(see Figure 1, Supplemental Digital Content 1, http://
links.lww.com/AJDP/A58).
Apocrine/Eccrine Differentiation
Decapitated cells, ducts (lined by cuboidal cells with an
eosinophilic cuticular border or vacuolated alveolar units).
Sebaceous Differentiation
Sebocytes and sebaceous ducts.
Follicular Differentiation
Bulb and papilla (papillary mesenchymal bodies includ-
ing circular-shaped papilla). Isthmus (cells with abundant
pink cytoplasm that cornify into compact keratin without
keratohyalin granules).
The degree of solar elastosis was evaluated by a pathol-
ogist, and those referred to as positive included from the
mildest (presence of single-scattered elastotic ﬁbers) to the
most severe (clumps of elastotic ﬁbers).
TABLE 1. Expression Pattern for the CK in Normal Skin and the Antibodies Used in the Immunohistochemistry17
Antigen Antibody-Clone Dilution Source Skin Targets
CK5/6 D5/16 B4 Ready to use DAKO, Glostrup, Denmark Epidermis (basal and parabasal cells), hair follicle
(all parts except the inner sheath), sebaceous gland (all
parts), sweat glands (all parts except secretory cells)
CK7 OV-TL 12/30 Ready to use DAKO, Glostrup, Denmark Sebaceous gland (sebocytes and undifferentiated cells)
and sweat glands (secretory cells)
CK14 LL002 1:100 Leica, Newcastle, United Kingdom Epidermis (all layers except the corneum layer), hair
follicle (all parts except the inner sheath), sebaceous
gland (all parts), sweat glands (all parts except
secretory cells)
CK15 LHK15 1:100 Leica, Newcastle, United Kingdom Hair follicle (only in the bulge and follicular germinative
cells), sebaceous gland (undifferentiated cells), and
sweat glands (only in secretory cells)
CK17 E3 Ready to use DAKO, Glostrup, Denmark Hair follicle (isthmus and outer sheath) and sebaceous
gland (only sebaceous ducts)
CK19 RCK108 Ready to use DAKO, Glostrup, Denmark Hair follicle (only in the bulge and follicular germinative
cells) and sweat gland (only secretory cells)
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RESULTS
The histoscore results with the expression of CK in each of
the 3 anatomical locations are reﬂected in Supplemental Digital
Content 1 (see Tables 1–3, http://links.lww.com/AJDP/A59).
CK5/6 expression showed signiﬁcant differences depending
on the anatomical BCC localization (adjusted P = 0.0002)
(Supplemental Digital Content 1, Table 4, http://links.lww.
com/AJDP/A60). Higher expression levels were detected in
facial lesions, whereas in trunk samples, low CK5/6 were
noted (Fig. 1), and nonphotoexposed samples exhibited an
intermediate level of CK5/6 expression. CK7 expression
showed also signiﬁcant differences depending on the BCC
localization (adjusted P = 0.009) (see Table 4, Supplemental
Digital Content 1, http://links.lww.com/AJDP/A60). Most
BCC samples arising in nonphotoexposed areas showed high
CK7 expression levels, whereas tumors located on the trunk
and face (sun-exposed areas) exhibited negative or barely
detectable levels (Fig. 1). In 5 of 30 facial samples, maximum
levels of CK7 histoscore were detected, which suggests that
different subsets of nodular facial BCCs regarding CK7
expression may exist (Figs. 2B, D). CK7 expression was also
detected in all BCC located on the inner part of the labia
majora (n = 4), a nonphotoexposed area devoid of hair fol-
licles, and BCC arising in the nipple, another hairless area
derived from a modiﬁed apocrine gland but located in an
intermittent photoexposed area (Figs. 3B, D). In addition, on
the axilla, a nonphotoexposed area where apocrine glands are
abundant, the expression of CK7 was also highly positive
(Figs. 2A, C). No statistically signiﬁcant differences in the
expression of CK14, CK15, CK17, and CK19 were detected
among the different anatomical localizations.
To assess possible differences between sun-exposed and
non–sun-exposed areas, all patients included in groups 1 and 2
(BCC from both chronic and intermittently photoexposed
areas) were compared with patients with lesions arising in
nonphotoexposed areas (group 3) (Table 2). No differences
were detected regarding CK5/6 expression when comparing
the degree of sun exposure. Only signiﬁcant differences for the
CK7 histoscore were detected (adjusted P = 0.002) in which
photoexposed areas showed a histoscore level of 86.06
(6101.63), whereas non–sun-exposed areas showed 181.67
(6104.57). Moreover, because the solar elastosis degree is
FIGURE 1. Representative images of
nodular and superficial BCCs. A,
Clinical image of a facial nodular
BCC. B, Clinical image of a superfi-
cial BCC from the trunk (C) nodular
BCC with negative CK7 expression.
D, Superficial BCC with low CK7
expression. E, Nodular BCC with
high CK5/6 expression. F, Superficial
BCC with low CK5/6 expression.
Original magnification: (C) ·100;
(D) ·40; (E) ·100; (F) ·40.
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an additional manner to measure sun exposure, as expected,
we have observed the same results while comparing CK
expression with either the elastosis degree or anatomical
location (Table 2 and see Table 5, Supplemental Digital
Content 1, http://links.lww.com/AJDP/A61). However, to
assess whether the data obtained in our CK proﬁle were
reliable enough in the degree of photoexposure, we generated
an ROC curve. We achieved an area under the curve of
a 95% (AUC 0.95), which indicates that the CK proﬁle cor-
relates with the localization of BCCs in sun-exposed and
non–sun-exposed areas (Fig. 4).
The secondary analysis of sex and age did not provide
relevant information (see Table 6, Supplemental Digital
Content 1, http://links.lww.com/AJDP/A62). As expected,
a relationship between those factors and the CK expression
was not detected, except for CK14. Intriguingly, CK14 shows
a signiﬁcant P value when compared with sex. The mean
histoscore of CK14 is slightly higher in women, but this
ﬁnding needs further investigation.
We have also assessed the correlation of keratins with
the histological BCC subtype irrespective of the anatomical
location. We have observed a signiﬁcant association of the
FIGURE 2. A, Nonphotoexposed
BCC on the axilla showing intense
expression of CK7 (C). B, Nodular
BCC on the face with a very intense
CK7 expression (D). Original mag-
nification: (C) ·40; (D) ·100.
FIGURE 3. Nonphotoexposed BCCs
showing high CK7 expression. A,
Vulvar BCC showing an intensive
CK7 expression (C). B, Ulcerated
BCC from the nipple with high CK7
expression (D). Original magnifica-
tion: (C) ·100; (D) ·40.
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expression of CK5/6 and the histological subtype. The mean
histoscore of this CK distinctly increases in nodular BCC
compared with superﬁcial ones (Table 3).
Finally, we have evaluated the association of CK
expression with the pattern of adnexal differentiation. The
samples were analyzed by the pathologist, and 3 groups of
differentiation were deﬁned: follicular (11 samples), apocrine/
eccrine (11 samples), and sebaceous (3 samples). In total, 37%
of the samples showed adnexal differentiation. Our data show
that CK7 is highly expressed in BCC with apocrine/eccrine
adnexal differentiation (see Table 7, Supplemental Digital
Content 1, http://links.lww.com/AJDP/A63). However,
because of the low number of samples, statistical analyses
are not reliable (ie, sebaceous differentiation).
DISCUSSION
Stem cells from the outer sheath of the hair follicle or
hair bulge are the most widely accepted theory on the cellular
origin of BCC. The histological similarities between some
clear-cut follicular tumors and BCC along with the low
frequency of BCC arising in hairless areas19,20 and the
development of BCC on follicular stem cell CK15+14 seem
to support this hypothesis. A possible origin from the
interfollicular epithelium has also been suggested, based on
studies in murine models.3,4,21
The underlying molecular alterations in BCC have been
studied extensively. In Gorlin syndrome, an autosomal
dominant genetic disorder characterized by the early develop-
ment of multiple BCCs, a constitutive mutation of the sonic
hedgehog pathway, alongside loss of the inhibitory function of
the membrane receptor, PTCH, has been seen. In sporadic
BCC, the sonic hedgehog pathway seems to be altered in
40%–60% of cases: 20%–40% as a result of a double mutation
in the PTCH1 tumor suppressor gene and in 10%–20% of
patients because of a single mutation of the SMO
oncogene.5–8 Ultraviolet (UV) radiation may induce deleterious
mutations in one or both alleles giving rise to pathway activa-
tion. In rare instances, alterations of the Wnt pathway and the
involvement of b-catenin or the ERK (MAP kinase) pathway
have been found.22,23
Not exceptionally, BCC may arise in non–sun-exposed
areas, such as the axilla or pubic region, and the etiopathogenic
role of UV exposure in those areas could not be responsible.
Additionally, in rare instances, BCC is observed to develop in
hairless areas such as the vulvar semimucosa or the nipple,
resulting in some controversies regarding its unequivocal fol-
licular origin. The CK proﬁle has been used to establish the
tissue origin of the tumor because it is commonly conserved
during cancerous transformation. However, it is important to
take into account different aspects when interpreting CK data:
the degree of tumor differentiation, the speciﬁcity and reliabil-
ity of antibodies, and also the tumor heterogeneity. To ascer-
tain the real niche involved in the origin of the neoplasia, the
CK proﬁle may be used in conjunction with other features such
as morphological data.24 In this work, the CK proﬁle we found
suggests a glandular origin of BCC arising in nonhairy and
non–sun-exposed areas, but our data cannot exclude the other
possible hypothesis. We have compared CK expression pat-
terns in a series of BCCs arising in areas chronically exposed
to sunlight, BCCs developing in areas with acute and intermit-
tent photoexposure, and BCCs arising in nonphotoexposed
areas. To our knowledge, no previous studies comparing CK
expression in BCC with the anatomical location or the degree
of exposure to sunlight have been published.
TABLE 2. Keratin Immunoexpression With Relation to Sun Exposure (Photoexposed vs. Nonphotoexposed)
Totals, n = 67 (100%) Photoexposed, n = 52 (77.61%) Nonphotoexposed, n = 15 (22.39%) P Adjusted P
CK7 107.46 (109.15) 86.06 (101.63) 181.67 (104.57) 0.001 0.002
CK5/6 158.21 (68.17) 160.58 (62.10) 150.00 (88.14) 0.58 0.60
CK19 47.39 (66.02) 41.83 (61.58) 66.67 (78.87) 0.11 0.20
CK14 215.67 (51.65) 219.23 (39.80) 203.33 (81.21) 0.51 0.28
CK17 209.33 (65.83) 212.98 (62.72) 196.67 (76.69) 0.44 0.40
CK15 24.22 (42.72) 19.00 (38.98) 42.86 (51.36) 0.08 0.06
Mean (and SD) presented for each marker, assessing the differences with a Mann–Whitney. P values are adjusted by sex and age obtained with an analysis of variance test.
FIGURE 4. ROC curve to assess the predictive value of the
multivariate logistic regression model to discriminate
the samples corresponding to the photoexposed versus
nonphotoexposed site. Estimation of the area under the curve
(AUC) = 0.95. This mathematical model allows us to predict
correctly where a BCC is located, photoexposed versus non-
photoexposed site, according to the CK profile (CK5/6, CK7,
CK14, CK17, and CK19) in the 95% of all the cases.
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CK7, a protein mainly expressed in the secretory cells of
sweat and sebaceous glands,17 showed a signiﬁcantly higher
expression in anatomic areas not exposed to sunlight and
speciﬁcally in apocrine gland-rich areas such as genital and
axillary regions and the nipple. Expression of CK7 is usually
observed in glandular epithelia such as mammary ductal,
pancreatic, or urothelial epithelia. CK7 is expressed also in
normal or tumor-derived apocrine and sebaceous glands12,17
and is considered a marker of mammary and extramammary
Paget disease.25,26 The possibility that BCC-developing
apocrine-rich areas such as the axilla and pubic areas may have
a common origin in the stem cells of apocrine gland could be
speculated. In fact, fewer than 100 cases of axillary BCCs have
been published in the literature27–29 (Fig. 2), but no studies
evaluating the CK proﬁle in such tumors have been reported.
A similar situation could be postulated for the rare observation
of BCC developing on the nipple,30 an apocrine-rich area,
devoid of hair follicles,31 in which we have also observed an
intense CK7 expression (Figs. 3B, D). Among other nonpho-
toexposed regions, in some cases of vulvar BCC developing
on the inner part of the labia majora, another hairless region
containing noncanonical sebaceous glands and no traces from
apocrine glands, we have also observed high expression of
CK7 (Figs. 3A, C), a feature that may also suggest a possible
sebaceous stem cell32 as the origin of these tumors.33
As expected, CK7 is also signiﬁcantly associated with
negative elastosis in agreement with its higher expression in
non–sun-exposed areas (see Table 5, Supplemental Digital
Content 1, http://links.lww.com/AJDP/A61). However, in our
series, 14 of 30 facial nodular BCCs were CK7 negative,
whereas 5 of 30 showed an intense CK7 expression (histoscore
300) (see Table 1, Supplemental Digital Content 1, http://
links.lww.com/AJDP/A61). Alessi et al12 analyzing different
series of BCC tumors showed that only a subgroup of BCC,
BCC with adnexal differentiation, exhibited high positivity of
CK7 (88%), whereas in the other subgroups, CK7 positivity
was only 42%. These authors postulated a possible glandular
origin of some BCC. Consistently, we have observed
apocrine/eccrine differentiation in non–sun-exposed samples
and follicular differentiation in facial samples. Then, we can
obtain a signiﬁcant association of CK7 expression and
apocrine/eccrine differentiation. This result is consistent with
our proposal, but we believe that the compilation of
additional samples (ie, sun-exposed BCC with eccrine or
sebaceous differentiation) will be required in future works
to conﬁrm these results (see Table 7, Supplemental Digital
Content 1, http://links.lww.com/AJDP/A61).
In our study, we have been unable to detect a correlation
between CK7 and CK19 expression levels. This feature has
been previously reported by other authors.17 We have observed
low levels of CK15, a potential marker of the stem cells of the
hair bulge,14 in all the BCCs studied. Similar results have been
described in previous studies.14,17 However, histoscore levels
of CK15 and CK19 were higher in nonphotoexposed regions,
although that was not statistically signiﬁcant (Table 2). Both
CKs are expressed in the secretory cells of sweat glands17 and
in the bulge of the hair follicle. As reported in other studies,
CK17 was positive in all the BCCs studied.12,15,34–36 CK17 is
a marker of follicular differentiation because it is weakly pos-
itive in the upper portion of the outer root sheath of the hair
follicle and is also expressed in the deep portion. CK14 was
also positive in all the BCCs studied.15,34–37 CK14 was ex-
pressed primarily in the subinfundibular outer sheath region of
the hair follicle.12 No signiﬁcant differences among the evalu-
ated groups were detected regarding the expression of this CK.
We have studied, as a secondary objective, whether
some differences are detected in the CK proﬁle in the different
BCC subtypes (nodular BCC, superﬁcial BCC, and inﬁltrative
BCC), and we obtained differences in CK5/6 expression in
nodular BCC. Facial BCC showed high levels of CK5/6, and
this association is not detected when comparing sun-exposed
and non–sun-exposed BCC (Table 2). Because we have
obtained almost all nodular BCCs from the face and most of
the superﬁcial ones from the trunk, the same signiﬁcant asso-
ciation is observed with the expression of CK5/6 and the
anatomical location (see Table 4, Supplemental Digital Con-
tent 1, http://links.lww.com/AJDP/A61). From our data, we
cannot, therefore, conclude whether the association is with
either the anatomical localization or the histological subtype.
However, Alessi et al 200812 did not ﬁnd any association of
CK5/6 expression with the histological subtype. Taking these
data into account, the possibility of a different expression of
CK5/6 depending on the anatomical localization, face (chronic
sun-exposed) versus trunk (discontinuous sun-exposed), is
open.
In conclusion, according to the expression of CK7 and
its correlation with BCCs located in nonphotoexposed areas,
we suggest that those BCCs are derived from simple glandular
epithelia. In agreement with this, nonphotoexposed areas such
as the axilla and pubis or in some special locations such as the
TABLE 3. Association of the BCC Subtype Group With CKs
Totals
BCC Subtypes
Inﬁltrative Nodular Superﬁcial P
CK7 107.46 (109.15) 141.67 (137.69) 103.68 (120.94) 108.33 (94.99) 0.46
CK5/6 158.21 (68.17) 158.33 (72.17) 196.32 (46.11) 115.00 (64.53) ,0.00001
CK19 47.39 (66.02) 50.00 (50.00) 46.32 (64.59) 48.33 (70.69) 0.89
CK14 215.67 (51.65) 233.33 (57.74) 222.06 (51.04) 206.67 (52.08) 0.52
CK17 209.33 (65.83) 200.00 (0.00) 219.12 (53.68) 199.17 (79.73) 0.81
CK15 24.22 (42.72) 58.33 (80.36) 25.76 (48.20) 18.75 (29.36) 0.55
Mean (and SD) are shown. P values from a Mann–Whitney test shown to assess the relationship.
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nipple or the vulvar semimucosa are rich in apocrine and
sebaceous glands. In such instances, etiopathogenic factors
other than ultraviolet light exposure could be responsible.
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